Global Bioenergies, a specialist in the conversion of plant resources into chemical compounds used in many cutting-edge fields such as cosmetics and energy, has announced an upward revision of its industrial ambitions and has decided to adjust its roadmap to focus from now on a project for a plant with greater production capacity than the ViaViridia plant, in order to meet the expectations of its industrial, commercial and financial contacts.
Sized to produce 10,000 tonnes of isobutene and derivatives per year (compared with 2,000 tonnes in the previous project), the plant will target the cosmetics market and then the sustainable aviation fuel market, for which Global Bioenergies has just obtained ASTM certification.
Marc Delcourt, co-founder and CEO of Global Bioenergies, comments: " We have delivered the first orders, and our first-half sales total 2.4 million euros. Guided by the current trend towards accelerated renewables, the strong market pull in this area, and technical advances in our direct process, we are modifying our roadmap. The commercial activities of the Pomacle unit, which certainly generate sales but have a low associated margin, are no longer a priority. We are now concentrating all our efforts on the construction of this larger plant, scheduled to come on stream at the end of 2027. At the same time, we are already starting to project our technology in other geographies and with other raw materials with international industrial groups."
For L'Oréal, the largest shareholder in Global Bioenergies via its investment fund Bold (Business Opportunities for L'Oréal Development), this high-capacity plant project reflects the environmental challenges and commitments made as part of its L'Oréal for the Future program.
Ana Kljuic, Vice President R&I L'Oréal for the Future & Green Science adds: "Our commitment by 2030 is to reach 95 % of bio-sourced ingredients, derived from abundant minerals or circular processes in our formulas. This new ambition for Global Bioenergies will make bio-sourced isobutene derivatives accessible at competitive prices to the cosmetics markets and, beyond that, enable everyone to play an active part in the environmental transition."
Global Bioenergies will publish a schedule of plant design and construction milestones by the end of fiscal 2023.
